In the next 5 years, what outcome is most likely for FDA management of accelerated approvals with subsequent failed confirmatory trials?

by Ashley E ·

Status quo with extended review timelines and limited FDA authority

Increased pharmaceutical manufacturer voluntary actions

Legislative change leading to additional FDA authority and actions

Name (Required)

Unique code (Required) What's this?

One vote per IP-Address allowed.

Strict checking is enabled.

One vote per browser session allowed.

One vote per user account allowed.

One vote per unique code allowed.

Users can vote multiple times without limitation.

(Once per minute) (Once per hour) (Once per day) (Once per week) (Once per month)

This content is neither created nor endorsed by StrawPoll.